abstract |
The present invention relates to dihydropyrazole compounds useful for the treatment of cell proliferative diseases, the treatment of disorders associated with KSP kinesin activity, and the inhibition of KSP kinesin. The invention further relates to compositions comprising these compounds and methods for their use in treating cancer in mammals. |